Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediatesVida Chitsazzadeh, Kenneth Y. Tsai, Curtis R. Pickering et al.|Nature Communications|2016Cited by 159
Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine ModelsLi Shen, Роберто Пили, Anette Sundstedt et al.|Cancer Immunology Research|2014Cited by 90
Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell linesNene N. Kalu, Faye M. Johnson, Tuhina Mazumdar et al.|Oncotarget|2017Cited by 70
PDK1 Mediates <i>NOTCH1</i> -Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR InhibitionVaishnavi Sambandam, Faye M. Johnson, Mitchell J. Frederick et al.|Clinical Cancer Research|2019Cited by 51
Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitorsMing Zhang, Faye M. Johnson, Ratnakar Singh et al.|Cancer Letters|2017Cited by 30